211 related articles for article (PubMed ID: 27528663)
1. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival.
Wang Y; Begley M; Li Q; Huang HT; Lako A; Eck MJ; Gray NS; Mitchison TJ; Cantley LC; Zhao JJ
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9810-5. PubMed ID: 27528663
[TBL] [Abstract][Full Text] [Related]
2. AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B.
van Gorp AG; van der Vos KE; Brenkman AB; Bremer A; van den Broek N; Zwartkruis F; Hershey JW; Burgering BM; Calkhoven CF; Coffer PJ
Oncogene; 2009 Jan; 28(1):95-106. PubMed ID: 18836482
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells.
McDonald IM; Grant GD; East MP; Gilbert TSK; Wilkerson EM; Goldfarb D; Beri J; Herring LE; Vaziri C; Cook JG; Emanuele MJ; Graves LM
J Biol Chem; 2020 Feb; 295(8):2359-2374. PubMed ID: 31896573
[TBL] [Abstract][Full Text] [Related]
4. Two functionally redundant isoforms of Drosophila melanogaster eukaryotic initiation factor 4B are involved in cap-dependent translation, cell survival, and proliferation.
Hernández G; Vázquez-Pianzola P; Zurbriggen A; Altmann M; Sierra JM; Rivera-Pomar R
Eur J Biochem; 2004 Jul; 271(14):2923-36. PubMed ID: 15233788
[TBL] [Abstract][Full Text] [Related]
5. Maternal embryonic leucine zipper kinase is stabilized in mitosis by phosphorylation and is partially degraded upon mitotic exit.
Badouel C; Chartrain I; Blot J; Tassan JP
Exp Cell Res; 2010 Aug; 316(13):2166-73. PubMed ID: 20420823
[TBL] [Abstract][Full Text] [Related]
6. eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways.
Shahbazian D; Parsyan A; Petroulakis E; Hershey J; Sonenberg N
Cell Cycle; 2010 Oct; 9(20):4106-9. PubMed ID: 20948310
[TBL] [Abstract][Full Text] [Related]
7. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.
Shahbazian D; Roux PP; Mieulet V; Cohen MS; Raught B; Taunton J; Hershey JW; Blenis J; Pende M; Sonenberg N
EMBO J; 2006 Jun; 25(12):2781-91. PubMed ID: 16763566
[TBL] [Abstract][Full Text] [Related]
8. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
[TBL] [Abstract][Full Text] [Related]
9. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of human translation initiation factor eIF4B is not affected by phosphomimetic amino acid substitutions S422D and S422E.
Shagam LI; Terenin IM; Andreev DE; Dunaevsky JE; Dmitriev SE
Biochimie; 2012 Dec; 94(12):2484-90. PubMed ID: 22750809
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth.
Edupuganti R; Taliaferro JM; Wang Q; Xie X; Cho EJ; Vidhu F; Ren P; Anslyn EV; Bartholomeusz C; Dalby KN
Bioorg Med Chem; 2017 May; 25(9):2609-2616. PubMed ID: 28351607
[TBL] [Abstract][Full Text] [Related]
12. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.
Kapadia B; Nanaji NM; Bhalla K; Bhandary B; Lapidus R; Beheshti A; Evens AM; Gartenhaus RB
Nat Commun; 2018 Feb; 9(1):829. PubMed ID: 29483509
[TBL] [Abstract][Full Text] [Related]
14. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
[TBL] [Abstract][Full Text] [Related]
15. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.
Perry NA; Fialkowski KP; Kaoud TS; Kaya AI; Chen AL; Taliaferro JM; Gurevich VV; Dalby KN; Iverson TM
Cell Signal; 2019 Nov; 63():109366. PubMed ID: 31352007
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma.
Kiseljak-Vassiliades K; Zhang Y; Kar A; Razzaghi R; Xu M; Gowan K; Raeburn CD; Albuja-Cruz M; Jones KL; Somerset H; Fishbein L; Leong S; Wierman ME
Endocrinology; 2018 Jul; 159(7):2532-2544. PubMed ID: 29790920
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells.
Sun H; Ma H; Zhang H; Ji M
Int J Biol Sci; 2021; 17(14):3875-3888. PubMed ID: 34671205
[TBL] [Abstract][Full Text] [Related]
18. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas.
Marie SK; Okamoto OK; Uno M; Hasegawa AP; Oba-Shinjo SM; Cohen T; Camargo AA; Kosoy A; Carlotti CG; Toledo S; Moreira-Filho CA; Zago MA; Simpson AJ; Caballero OL
Int J Cancer; 2008 Feb; 122(4):807-15. PubMed ID: 17960622
[TBL] [Abstract][Full Text] [Related]
19. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
[TBL] [Abstract][Full Text] [Related]
20. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
